SeaSpine Holdings Corporation (NASDAQ:SPNE) Files An 8-K Amendment to Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics

SeaSpine Holdings Corporation (NASDAQ:SPNE) Files An 8-K Amendment to Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics

Story continues below

Item 5.05 Amendments to the Registrants Code of Ethics, or Waiver
of a Provision of the Code of Ethics.

As part of its review of our corporate governance principles, on
June 14, 2017, our board of directors adopted amendments to our
Code of Business Conduct and Ethics (the Code). The Code is
applicable to all our employees, officers and directors. In
addition to technical, administrative and other non-substantive
amendments, the Code was amended to clarify that individuals
subject to the Code are required to comply with our comprehensive
compliance program when conducting business with Healthcare
Professionals from foreign countries and to clarify that nothing
in the Code (or in any other agreement any employee, officer or
director may have signed with our company, despite the language
in such agreement) is intended to limit the ability of any of our
employees, officers or directors to file a charge or complaint
with any government agency or commission, and does not limit
their ability to communicate with or otherwise participate in an
investigation or proceeding that may be conducted by a government
agency or commission. The amendments took effect upon adoption.
The foregoing description of the Code does not purport to be
complete and is qualified in its entirety by reference to the
complete text of the Code, which is filed as an exhibit to this
report and incorporated herein by reference. The Code is also
publicly available on our website at http://www.seaspine.com.
Item 5.07 Submission of Matters to a Vote of Security Holders.
We held our annual meeting of stockholders on June 14, 2017. The
final results of the matters submitted to a vote of stockholders
at such meeting are as follows:
Proposal 1: Each of the three Class II nominees for our board of
directors were elected to serve for a three-year term to expire
at our 2020 annual meeting of stockholders by the votes set forth
below.
Nominee
Votes For
Votes Against
Absentions
Broker Non-Votes
Cheryl R. Blanchard, Ph.D.
7,317,296
1,476,513
2,088,164
Kirtley (Kirt) C. Stephenson
7,313,295
1,480,514
2,088,164
James M. Sullivan
7,285,773
1,508,036
2,088,164
Proposal 2: Our stockholders ratified the appointment of RSM US
LLP as our independent registered public accounting firm for the
fiscal year ending December 31, 2017 by the votes set forth
below.
Votes For
Votes Against
Absentions
Broker Non-Votes
10,465,424
377,768
38,781
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
The information set forth in the Exhibit Index following the page
hereto is incorporated herein by reference.


About SeaSpine Holdings Corporation (NASDAQ:SPNE)

SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development, manufacture and marketing of orthobiologics and spinal fusion hardware segment. It has a portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures in the lumbar, thoracic and cervical spine. It offers a portfolio of orthobiologics and spinal fusion hardware products for the treatment of patients suffering from spinal and other orthopedic disorders. Its orthobiologics products consist of a range of bone graft substitutes that are designed to improve bone fusion rates following a range of orthopedic surgeries, including spine, hip and extremities procedures.

An ad to help with our costs